Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Arrhythmia and Electrophysiology
Search: search_blue_button Advanced Search
Circulation: Arrhythmia and Electrophysiology. 2008;1:370-378
Published online before print December 2, 2008, doi: 10.1161/CIRCEP.108.788349
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
1/5/370    most recent
CIRCEP.108.788349v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, D. W.
Right arrow Articles by George, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, D. W.
Right arrow Articles by George, A. L., Jr
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrowRelated Article

Original Articles

Malignant Perinatal Variant of Long-QT Syndrome Caused by a Profoundly Dysfunctional Cardiac Sodium Channel

Dao W. Wang, MD, PhD; Lia Crotti, MD, PhD; Wataru Shimizu, MD, PhD; Matteo Pedrazzini, BSc; Francesco Cantu, MD; Paolo De Filippo, MD; Kanako Kishiki, MD; Aya Miyazaki, MD; Tomoaki Ikeda, MD, PhD; Peter J. Schwartz, MD and Alfred L. George, Jr, MD

From the Department of Medicine (D.W.W., A.L.G.), Vanderbilt University, Nashville, Tenn; Section of Cardiology (L.C., P.J.S.), Department of Lung, Blood and Heart, University of Pavia; Department of Cardiology (L.C., P.J.S.) and Molecular Cardiology Laboratory (L.C., M.P., P.J.S.), IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy; Division of Cardiology (W.S.), Department of Internal Medicine, Department of Pediatric Cardiology (K.K., A.M.), Department of Perinatology (T.I.), National Cardiovascular Center, Osaka, Japan; Department of Cardiology (F.C., P.D.F.), Ospedali Riuniti, Bergamo, Italy; Department of Pharmacology (A.L.G.), Vanderbilt University, Nashville, Tenn.

Correspondence to Alfred L. George Jr, MD, Division of Genetic Medicine, 529 Light Hall, Vanderbilt University, Nashville TN 37232-0275. E-mail al.george{at}vanderbilt.edu

Received April 24, 2008; accepted September 15, 2008.

Background— Inherited cardiac arrhythmia susceptibility contributes to sudden death during infancy and may contribute to perinatal and neonatal mortality, but the molecular basis of this risk and the relationship to genetic disorders presenting later in life is unclear. We studied the functional and pharmacological properties of a novel de novo cardiac sodium channel gene (SCN5A) mutation associated with an extremely severe perinatal presentation of long-QT syndrome in unrelated probands of different ethnicity.

Methods and Results— Two subjects exhibiting severe fetal and perinatal ventricular arrhythmias were screened for SCN5A mutations, and the functional properties of a novel missense mutation (G1631D) were determined by whole-cell patch clamp recording. In vitro electrophysiological studies revealed a profound defect in sodium channel function characterized by {approx}10-fold slowing of inactivation, increased persistent current, slowing of recovery from inactivation, and depolarized voltage dependence of activation and inactivation. Single-channel recordings demonstrated increased frequency of late openings, prolonged mean open time, and increased latency to first opening for the mutant. Subjects carrying this mutation responded clinically to the combination of mexiletine with propranolol and survived. Pharmacologically, the mutant exhibited 2-fold greater tonic and use-dependent mexiletine block than wild-type channels. The mutant also exhibited enhanced tonic (2.4-fold) and use-dependent block ({approx}5-fold) by propranolol, and we observed additive effects of the 2 drugs on the mutant.

Conclusions— Our study demonstrates the molecular basis for a malignant perinatal presentation of long-QT syndrome, illustrates novel functional and pharmacological properties of SCN5A-G1631D, which caused the disorder, and reveals therapeutic benefits of propranolol block of mutant sodium channels in this setting.

Key Words: antiarrhythmia agents • arrhythmia • death, sudden • heart arrest • ion channels


 

CLINICAL PERSPECTIVE

The online-only Data Supplement is available at http://circep.ahajournals.org/cgi/content/full/1/5/378/DC1.


Related Article

Malignant Perinatal Variant of Long-QT Syndrome Caused by a Profoundly Dysfunctional Cardiac Sodium Channel
Dao W. Wang, Lia Crotti, Wataru Shimizu, Matteo Pedrazzini, Francesco Cantu, Paolo De Filippo, Kanako Kishiki, Aya Miyazaki, Tomoaki Ikeda, Peter J. Schwartz, and Alfred L. George, Jr
Circ Arrhythm Electrophysiol 2008 1: 370-378. [Abstract] [Full Text] [PDF]